ATOSSA THERAPEUTICS, INC. (ATOS) Operating cash flow 2016–2025
ATOSSA THERAPEUTICS, INC. (ATOS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$29.8MFY2025 · since FY2016: -$5.4M → -$29.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.8M | -41.5% |
| FY2024 | -$21.0M | -0.4% |
| FY2023 | -$20.9M | -0.9% |
| FY2022 | -$20.8M | -26.0% |
| FY2021 | -$16.5M | -42.4% |
| FY2020 | -$11.6M | -26.7% |
| FY2019 | -$9.1M | -1.9% |
| FY2018 | -$9.0M | -35.9% |
| FY2017 | -$6.6M | -22.7% |
| FY2016 | -$5.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ATOS financial trends
ATOS RevenueATOS Net incomeATOS Net marginATOS Gross profitATOS Gross marginATOS Operating incomeATOS Operating marginATOS Free cash flowATOS Capital expendituresATOS Return on equityATOS Stock buybacksATOS Dividends paidATOS Total assetsATOS Total liabilitiesATOS Shareholders’ equityATOS overview →